Litcius/Paper detail

Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti–PD-1 therapy

Adriana Hepner, Victoria Atkinson, James Larkin, Rebecca A. Burrell, Matteo S. Carlino, Douglas B. Johnson, Lisa Zimmer, Katy K. Tsai, Oliver Klein, Serigne Lo, Andrew Haydon, Prachi Bhave, Megan Lyle, Lalit Pallan, Inês Pires da Silva, Camille L. Gérard, Olivier Michielin, Georgina V. Long, Alexander M. Menzies

2021European Journal of Cancer17 citationsDOI

Topics & Concepts

IpilimumabMedicineInternal medicineAdverse effectNivolumabImmunotherapyMelanomaCombination therapyCohortOncologySurgeryCancerCancer researchCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways